South Africa has put a hold on the rollout of the AstraZeneca COVID-19 vaccine.
Health Minister Dr Zweli Mkhize last night announced that a team of experts would give guidance on the way forward with this vaccine.
Early scientific data released on Sunday revealed that the vaccine offered “minimal protection” against mild disease for people infected with the second variant of the coronavirus discovered at the end of last year.
Clinical trial data from the AstraZeneca COVID-19 vaccine study locally revealed that it had a 22% efficacy against the 501Y.V2 coronavirus variant.
Minister Mkhize said that at the time that government acquired the vaccines, this clinical trial data had not been concluded.
More Stories
SA’s Biggest-Ever Digital Billboard Is Coming – And It’s Solar
Eskom Not Ruling Out Stage 8 Power Cuts
Walus Will Meet His Fate – Lesufi
KZN Residents Unhappy With Slow Pace Of Repairs
Jukskei Death Toll Rises To 15
Covid-19 Numbers Up, But Experts Say No Need To Panic
Dut And Lenovo Launches Robogirl 2022 To Train Young Female Learners On Coding And Robotics
EFF To Open Racial Discrimination Case With HRC Following Racist CT Pub Incident
NEC Resolves For Ramaphosa To Remain ANC President
Mabuza Implicated In R35bn Land Claim Scam
Parts Of Joburg Without Power After Severe Storms
MPs Vote To Move Phala Phala Debate To Next Week